NewsRx Logo Login/Signup
Home Newsletters Products Library About Us Contact -- Search NewsRx

NewsRx | Free Trials
Advertisement
VerticalNews | Global Warming
Advertisement
NewsRx | Free Trials
Advertisement
----------
------------
NewsRx on Facebook
-----
Press Release Submissions
PR Login
*
*

Women's Health Weekly

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Women's Health Weekly

Learn More

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Buy Now



Cancer Genetics



Recent findings in cancer genetics described



June 30th, 2005

Cancer genetics research advances have been reported from Australia, Netherlands and the United Kingdom.

Study 1: BARD1 was implicated as a potential tumor suppressor.

"The BARD1 gene is mutated in a subset of breast and ovarian cancers, implicating BARD1 as a potential tumor suppressor. BARD1 gains a ubiquitin E3 ligase activity when heterodimerized with BRCA1, but the only known BRCA1-independent BARD1 function is a p53-dependent proapoptotic activity stimulated by nuclear export to the cytoplasm," investigators in Australia reported.

"We described previously the nuclear-cytoplasmic shuttling of BARD1, and in this study, we...


Source: Women's Health Weekly (2005-06-30)

NewsRx Passes
Advertisement
More Articles

------------------------
Security by Verisign PR Login